Welcome to the Board of Podiatric Medical Examiners
The State Board of Podiatric Medical Examiners (the "Board") operates under the provisions of Title 16 of the Health Occupations Article of the Annotated Code of Maryland. The Board is the licensing authority of podiatrists in the State of Maryland. The Board is mandated to protect the public by regulating the practice of podiatry in Maryland, by licensing qualified podiatrists, establishing fees, maintaining a current roster of all licensees, administration of licensing examinations, enforcing current statutes and regulations, adopting new regulations to carry out provisions of the Title, suggesting new changes to the Title to keep abreast of trends and practice issues, adopting standards of practice for podiatrists, verification of credentials, issuance of licenses, establish requirements for and verification of completion of continuing education, investigation of complaints based on alleged violations of regulations and statutes, formal and informal disciplining of licensees, create committees as deemed appropriate to advise the Board.
The program is 100% special funded. The fund is supported exclusively by revenues generated by licensing fees. The Board consists of seven members appointed by the Governor with the advice of the Secretary. Five members of the Board are licensed podiatrists and two members represent the consumer public.
Important News Updates
INSTRUCTIONS FOR PODIATRISTS WITH PERMIT TO DISPENSE PRESCRIPTION DRUGS
A Permit to Dispense Prescription Drugs from the Maryland Board of Podiatry allows a podiatrist to dispense prescription drugs to a patient only when the pharmacy is not conveniently available to the patient, as determined by the patient. If prescriptions will be dispensed in more than one location or by more than one podiatrist, a separate dispensing permit is required for each. Dispensing Permits are valid only at the location identified on the Permit. --More > >
ADVERTISING OFF LABEL USE OF LASERS FOR TREATING TOENAIL FUNGUS
Pursuant to the Board’s Regulations, advertisements may not include statements containing misrepresentations of facts that are likely to mislead or deceive because in context the statement makes only partial disclosure of relevant facts; and likely to create false or unjustified expectations of favorable results. Code of Maryland Regulations (COMAR) 10.40.06.03. This applies to devices not FDA approved or cleared for the treatment of toenail fungus, and must contain a statement indicating that the device has not received FDA approval or clearance.
Tanya Sellers-Hannibal, D.P.M., President
Jay S. LeBow, D.P.M., Vice President
Jay H. Boyar, Eds, Secretary / Treasurer
Zachary L. Chattler, D.P.M., Member
Barbara A. Crosby, RN, BSN, Member
Craig Friedman, D.P.M., Member
Todd A. Harrison, D.P.M., Member
Eva Schwartz, Executive Director
Sheri Henderson, Administrative Officer
Elizabeth Amspacher, Administrative Specialist
Richard Bloom, A.A.G., Board Counsel